Fig. 3From: BIRC3 and BIRC5: multi‐faceted inhibitors in cancerSchematic representation of the pathway involving the non-canonical NF-kB activation through NF-kB-inducing kinase (NIK/MAP3K14), modulated by cIAPsBack to article page